Tag: Aspirin
More Evidence Daily Aspirin May Protect Against GI Cancer
Four-year study found survival doubled for GI cancer patients who took low-dose pill each day
USPSTF Recommendations for Aspirin Use Vary by Age
Recommended for some patients aged 50 to 59 years; insufficient evidence for those <50, ≥70
Low-Dose Aspirin, Other NSAIDs May Lower Colorectal Cancer Risk
Findings for consistent use over 5 or more years
CDC: Aspirin Use Common Among Americans With Heart Disease
Clinical and community-based approaches should be used to increase aspirin use among low-use groups
Review: Short vs. Long Duration Dual Antiplatelet Tx After Stent
Longer DAPT linked to reduced stent thrombosis and myocardial infarction, increased bleeding, mortality
ATS: Aspirin Use Linked to Slower Progression of Emphysema
Slower progression of percent emphysema on CT after adjustment for multiple variables
Over Half of Middle-Age, Older Americans Take Daily Aspirin
Having discussed aspirin with provider is the strongest predictor of regular use
AACR: Regular Aspirin Use Linked to Lower GI Cancer Risk
Greatest benefit from aspirin required taking it for at least 16 years
Aspirin Use Not Found to Benefit Prostate Cancer Mortality
Increased risks of mortality restricted to aspirin use after the diagnosis of prostate cancer
Individual Short-Term Responses to Antiplatelet Therapy Vary
Variability within individuals from pre-discharge to one week after discharge, but not thereafter
